ClinicalTrials.govpublic full text
A Study of Intermittent Oral Dosing of ASP1517 in Non-Dialysis Chronic Kidney Disease Patients With Anemia
chronic kidney disease, roxadustat, anemia, non-dialysis chronic kidney disease, asp1517, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 879712
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.